Beijing Winsunny Pharmaceutical CO.LTD (601089) — Cash Flow Quality Index
Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Cash Flow Quality Index of 1.41x as of December 2024. Operating cash flow of CN¥690.75 Million exceeds net income of CN¥488.67 Million, indicating high earnings quality where cash backs reported profits. Explore Beijing Winsunny Pharmaceutical CO.LTD (601089) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Beijing Winsunny Pharmaceutical CO.LTD Cash Flow Quality Index (2020–2024)
Historical Cash Flow Quality Index for Beijing Winsunny Pharmaceutical CO.LTD across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 601089 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
Year-by-year earnings quality comparison for Beijing Winsunny Pharmaceutical CO.LTD. For live market cap and the full company financial profile, see how much is Beijing Winsunny Pharmaceutical CO.LTD worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.41x | CN¥690.75 Million | CN¥488.67 Million | ▲ +24.3% |
| 2023 | 1.14x | CN¥555.90 Million | CN¥488.77 Million | ▼ -24.4% |
| 2022 | 1.50x | CN¥659.76 Million | CN¥438.46 Million | ▼ -9.3% |
| 2021 | 1.66x | CN¥528.02 Million | CN¥318.12 Million | ▲ +12.8% |
| 2020 | 1.47x | CN¥386.65 Million | CN¥262.71 Million | — |